Invention Grant
- Patent Title: Benzimidazolium compounds
- Patent Title (中): 苯并咪唑化合物
-
Application No.: US14330020Application Date: 2014-07-14
-
Publication No.: US09328131B2Publication Date: 2016-05-03
- Inventor: Joerg Kley , Sara Frattini , Dieter Hamprecht
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP13176483 20130715
- Main IPC: C07D403/02
- IPC: C07D403/02 ; C07F9/6558 ; A61K45/06 ; C07D401/14 ; A61K31/497 ; C07D403/12 ; C07D405/14 ; C07F9/572 ; C07F9/40

Abstract:
The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.
Public/Granted literature
- US20150018314A1 NOVEL BENZIMIDAZOLIUM COMPOUNDS Public/Granted day:2015-01-15
Information query